IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q3 2014 Holdings

Filed 2014-11-13 | 18 holdings | $515.7K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2014-11-17) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Zeltiq Aesthetics IncACOM98933Q108$58.8K2,597,74211.4%
Esperion Therapeutics Inc(ESPR)ACOM29664W105$50.3K2,054,5949.7%
T2 Biosystems IncACOM89853L104$45.7K2,523,3008.9%
Loxo Oncology IncACOM548862101$45.3K3,452,4938.8%
Catalent Inc(CTLTEUR)ACOM148806102$44.1K1,761,2258.5%
Chimerix Inc(CMRXEUR)ACOM16934W106$42.1K1,522,9438.2%
Versartis IncACOM92529L102$37.9K1,994,5687.3%
TransEnterix IncACOM NEW89366M201$36.3K8,335,8197.0%
Cempra IncACOM15130J109$36.1K3,293,0607.0%
Durata Therapeutics IncACOM26658A107$25.7K2,030,1755.0%
Ambit Biosciences CorpACOM02318X100$25.4K1,650,1564.9%
Agile Therapeutics Inc(AGRXUSD)ACOM00847L100$15.9K2,171,8313.1%
Pernix Therapeutics Hldgs inACOM71426V108$15.4K2,010,0003.0%
Roka Bioscience IncACOM775431109$11.3K1,122,4172.2%
Sorrento Therapeutics Inc(SRNE)ACOM NEW83587F202$8.0K1,763,5001.5%
Lombard MED IncACOMG55598109$6.8K886,3631.3%
Intersect ENT IncACOM46071F103$5.4K350,0001.1%
MEI Pharma IncACOM NEW55279B202$5.3K761,8001.0%
Zeltiq Aesthetics IncCallCOM98933Q108$65743,2610.2%
Cempra IncCallCOM15130J109$42940,0000.1%
Pernix Therapeutics Hldgs inCallCOM71426V108$9010,0000.0%